LIFTT invests in RAAAM Memory Technologies

2025-11-04T17:13:54+01:004 November 2025|

RAAAM Memory Technologies, a startup company which developed the next-generation on-chip memory technology, announced today that it has completed an over-subscribed USD 17.5M Series A funding round. The round was led by NXP Semiconductors and included a leading multinational networking corporation, IAG Capital, EIC Fund, LIFTT, Alumni Ventures and all

Sparrow Quantum Secures €21.5 Million to Accelerate Photonic Quantum Innovation in Europe

2025-04-11T09:30:41+02:0011 April 2025|

Sparrow Quantum, a leading European supplier of photonic quantum chips, has secured €21.5 million in Series A funding to accelerate the development and commercialization of its world-leading quantum chip technology. The investment round was led by PensionDanmark, with strong backing from EIFO and Novo Holdings and additional investments from existing

Northern Gritstone leads £3.5 million Seed Round investment in pioneering ingredients technology company MicroLub

2024-10-21T10:41:23+02:0021 October 2024|

MicroLub a University of Leeds spinout has developed a new ingredients technology that: Replaces fats and oils with water without losing the sensory food experience Addresses key consumer demands for lower-calorie and sustainable food options Targets dairy and plant-based food and food ingredients markets 21st October 2024 - Northern Gritstone,

LIFTT participates in $26m investment round in Evergreen Theragnostics

2024-04-17T10:47:45+02:0017 April 2024|

Evergreen Theragnostics, a clinical-stage radiopharmaceutical company, today announced the successful completion of a $26M capital raise supported both by existing shareholders and new institutional investors, Petrichor and LIFTT. The financing advances Evergreen’s novel discovery pipeline into clinical trials, supports commercialization of its diagnostic agent, and further expands CDMO capabilities to

LIFTT invests in immuno-oncology company NeoPhore

2024-02-01T10:35:01+01:001 February 2024|

NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces a further extension of £9.6m (approx. USD $12.2m) to its Series B financing round. With participation from its existing syndicate, CPF managed by Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG, and the addition of three

1000Farmacie Secures $25 Million in Series A Funding, with an Additional $10 Million in Second Tranche Extension

2023-07-27T10:14:19+02:0027 July 2023|

1000Farmacie, the leading Italian pharmacy marketplace, announced today the successful completion of its second tranche of Series A funding, raising a total of $25 million. The company secured an additional $10 million in the extension round, highlighting investor confidence and further accelerating the company's mission to revolutionize the pharmaceutical industry.

Go to Top